Honda, Y., Kessoku, T., Ogawa, Y., Tomeno, W., Imajo, K., Fujita, K., . . . Nakajima, A. (2017). Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. Sci Rep.
Chicago-стиль цитированияHonda, Yasushi, et al. "Pemafibrate, a Novel Selective Peroxisome Proliferator-activated Receptor Alpha Modulator, Improves the Pathogenesis in a Rodent Model of Nonalcoholic Steatohepatitis." Sci Rep 2017.
MLA-цитированиеHonda, Yasushi, et al. "Pemafibrate, a Novel Selective Peroxisome Proliferator-activated Receptor Alpha Modulator, Improves the Pathogenesis in a Rodent Model of Nonalcoholic Steatohepatitis." Sci Rep 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.